Clinical efficacy of first and second series of peptide receptor radionuclide therapy in patients with neuroendocrine neoplasm: a cohort study.
M D ZachoP IversenG E VilladsenSimon Mark Dahl JørgensenA K ArveschougHenning GrønbækG DamPublished in: Scandinavian journal of gastroenterology (2021)
PRRT is an effective therapy with long-term PFS and OS, especially in G1 and G2 NENs, and with better prognosis in GI-NEN compared with BP-NENs. OS and PFS was shorter after the second series of PRRT compared with the first, however results were still encouraging.